Jing-Lin Xia (Jinglin Xia)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Wastewater Treatment

Cell Proliferation

Top Venues

Journal of experimental & clinical cancer research : CR

Cancer medicine

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiao-Jing Du, Zhuoran Qi, Jinzhi Xu, Mengzhou Guo, Xingxing Zhang, Zhijie Yu, Xin Cao, Jing-Lin Xia
Loss of GABARAPL1 confers ferroptosis resistance to cancer stem-like cells in hepatocellular carcinoma. Molecular oncology 16 (20) (2022)
Feng Qi, Wenxing Qin, Yao Zhang, Yongde Luo, Bing Niu, Quanlin An, Biwei Yang, Keqing Shi, Zhijie Yu, Junwei Chen, Xin Cao, Jing-Lin Xia
Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Qian-Wen Rao, Shi-Long Zhang, Meng-Zhou Guo, Fei-Fei Yuan, Jia-Lei Sun, Feng Qi, Li-Shun Wang, Bi-Wei Yang, Jing-Lin Xia
Sulfiredoxin-1 is a promising novel prognostic biomarker for hepatocellular carcinoma. Cancer medicine 9 (22) (2020)